IGF2BP1 fosters an immunosuppressive tumor microenvironment in high-risk neuroblastoma, contributing to their resistance to immunotherapy.
Saved in:
| Title: | IGF2BP1 fosters an immunosuppressive tumor microenvironment in high-risk neuroblastoma, contributing to their resistance to immunotherapy. |
|---|---|
| Authors: | Dhamdhere MR; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Gowda CP; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Imamura Y; Department of Neuroscience & Experimental Therapeutics, The Pennsylvania State University University College of Medicine, Hershey, PA, USA., Wang HG; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA., Schell TS; Department of Microbiology and Immunology, The Pennsylvania State University College of Medicine, Penn State Cancer Institute, Hershey, PA, USA., Spiegelman VS; Division of Pediatric Hematology and Oncology, Department of Pediatrics, The Pennsylvania State University College of Medicine, Hershey, PA, USA. |
| Source: | Oncoimmunology [Oncoimmunology] 2025 Dec 31; Vol. 14 (1), pp. 2584408. Date of Electronic Publication: 2025 Dec 02. |
| Publication Type: | Journal Article; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural |
| Journal Info: | Publisher: Taylor & Francis Country of Publication: United States NLM ID: 101570526 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2162-402X (Electronic) Linking ISSN: 21624011 NLM ISO Abbreviation: Oncoimmunology Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 2162-402X |
|---|---|
| DOI: | 10.1080/2162402X.2025.2584408 |
